- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J0897
    - J1756
  conditions:
    all_of:
    - dx_in_value_set: vs_heart_failure_reduced_ef_2025_09
    - has_flag: ejection_fraction_35_or_less
    - has_flag: optimal_medical_therapy_3_months
    - has_flag: life_expectancy_1_year_plus
    none_of:
    - dx_in_value_set: vs_reversible_cardiomyopathy_2025_09
    - has_flag: incessant_vt_vf
  logic:
    outcome: PA_REQUIRED
    notes: "ICD/CRT-D requires HFrEF with EF \u226435%, optimal medical therapy \u2265\
      3 months, life expectancy >1 year"
  precedence: 95
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_heart_failure_guidelines_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_06f4b81c75bc
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '33249'
    - '33264'
    - '33265'
  conditions:
    all_of:
    - dx_in_value_set: vs_heart_failure_reduced_ef_2025_09
    - has_flag: qrs_duration_150_ms_plus
    - has_flag: lbbb_morphology
    - has_flag: nyha_class_ii_iv
    - has_flag: optimal_medical_therapy_3_months
    none_of:
    - has_flag: atrial_fibrillation_permanent
  logic:
    outcome: PA_REQUIRED
    notes: "CRT requires HFrEF, QRS \u2265150ms with LBBB, NYHA II-IV, optimal medical\
      \ therapy"
  precedence: 90
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_heart_failure_guidelines_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_54b516a1d909
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J1303
    - J1304
  conditions:
    all_of:
    - dx_in_value_set: vs_heart_failure_reduced_ef_2025_09
    - has_flag: ace_inhibitor_intolerant
    - has_flag: nyha_class_ii_iv
    none_of:
    - dx_in_value_set: vs_angioedema_history_2025_09
    - has_flag: pregnancy
  logic:
    outcome: PA_REQUIRED
    notes: Entresto requires HFrEF with ACE inhibitor intolerance, NYHA II-IV, no
      angioedema history
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_heart_failure_guidelines_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_85437977c536
- type: EDIT
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '93306'
  conditions:
    all_of:
    - dx_in_value_set: vs_heart_failure_2025_09
    - has_flag: stable_symptoms
    none_of:
    - has_flag: medication_change_recent
    - has_flag: clinical_deterioration
  logic:
    outcome: APPROVE
    notes: Routine echo monitoring approved for stable HF patients every 6-12 months
  precedence: 75
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_heart_failure_guidelines_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_42334077c4f0
